<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>BioToday.com [新着ニュース]</title>
	<description>BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。</description>
	<link>http://www.biotoday.com/news.cfm</link>
	<managingEditor>biotoday@biotoday.com</managingEditor>
	<copyright>Copyright &#169; 2026 BioToday Ltd. All Rights Reserved.</copyright>
	<lastBuildDate>Sat, 16 May 2026 15:16:12 +0900</lastBuildDate>
	<language>ja</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title>[企業] AmgenのTepezzaの領分を奪うはずだった甲状腺眼症薬からAlumisが手を引く</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109864&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109864&amp;ref=rss</guid>
		<category>ビジネス / 会社運営 / 業績発表・予想</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 16 May 2026 15:16:12 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109864&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 膀胱切除するも癌細胞が残る膀胱癌患者へのRocheのTecentriq使用を米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109863&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109863&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 16 May 2026 12:06:01 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109863&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 癌の疲労にメチルフェニデートの類いが有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109862&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109862&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 16 May 2026 11:03:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109862&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 妊婦のインフルエンザが特に有害なのはウイルス感知役TLR7の暴走のせいらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109861&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109861&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 16 May 2026 08:45:56 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109861&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AnthropicとGates Foundationが協力して健康、教育、農業のAI頼りの道具を作る</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109860&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109860&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 産学公民連携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 16 May 2026 08:10:43 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109860&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Aardvark社がすでに自主停止した過食薬Ph3試験を米国FDAが差し止め</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109859&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109859&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 15 May 2026 16:56:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109859&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] EyePoint社の長持ちなVEGF受容体阻害薬のWet AMD相手のPh3試験が関門通過</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109858&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109858&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 15 May 2026 16:36:54 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109858&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Regenxbioのデュシェンヌ型筋ジストロフィー遺伝子治療のPh3試験目標達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109857&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109857&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 15 May 2026 13:41:56 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109857&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 筋層浸潤膀胱癌へのAstraZenecaのImfinzi術前後投与がPh3試験生存改善達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109856&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109856&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 15 May 2026 11:39:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109856&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Ph2試験主目標未達にも怯まずBiogenのアルツハイマー病薬が大詰め段階に進む</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109855&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109855&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 15 May 2026 10:34:27 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109855&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ASS1遺伝子変異を正すプライム編集でCTLN1マウスの尿素生成回復、生存改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109854&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109854&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 15 May 2026 09:51:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109854&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 感覚神経からのFGF1がどうやら腱の変性を防ぐ働きを担う</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109853&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109853&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 15 May 2026 08:50:12 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109853&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脳に挿したカテーテルからの脳脊髄液生理指標のほぼ即時測定法NeuroSense開発</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109852&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109852&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 15 May 2026 08:37:47 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109852&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] uPAR標的CAR-Tで膠芽腫を治療しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109851&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109851&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 14 May 2026 16:24:43 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109851&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 一本鎖切断で事足りる遺伝子編集(prime editing)でSCN1A変異マウスの病態改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109850&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109850&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 14 May 2026 15:52:59 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109850&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脳へのアデニン塩基編集投与でドラベ症候群マウスの発作が減って生存が延長</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109849&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109849&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 14 May 2026 15:25:40 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109849&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] NK細胞のNKG2A阻害が老化線維芽細胞を始末して肺線維症の解消を促しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109848&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109848&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 14 May 2026 13:22:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109848&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 米国FDAが血液癌治療2つを承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109847&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109847&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 14 May 2026 10:46:16 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109847&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] FosunがAriBioに6000万ドルを払ってアルツハイマー病薬AR1001全世界権利取得</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109846&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109846&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 14 May 2026 08:57:46 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109846&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Kyverna社の自己免疫疾患治療CAR-T・miv-celの段階的承認申請開始</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109845&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109845&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認申請</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 14 May 2026 08:21:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109845&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 武田薬品がPh1試験済みの悪心嘔吐薬TAK-004開発中止</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109844&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109844&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験 || 開発 / 臨床試験 / 中止</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 14 May 2026 07:39:42 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109844&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Alphabetが設立したAI創薬のIsomorphic Labsが21億ドル調達</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109843&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109843&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 13 May 2026 16:28:59 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109843&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Alkermesのナルコレプシー薬Lumryzの特発性過眠症Ph3試験成功</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109842&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109842&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 13 May 2026 15:34:07 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109842&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Pfizer/Arvinasの承認されたての乳癌薬Veppanuの引き取り手がRigel社に決まる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109841&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109841&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 13 May 2026 14:57:16 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109841&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] BMSが中国Hengrui社の癌/血液分野の駆け出しの4品の中国外での権利を手にする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109840&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109840&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 13 May 2026 14:20:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109840&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Enterprise社の上皮ナトリウムチャネル阻害薬が嚢胞性線維症Ph2試験で効果あり</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109839&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109839&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 13 May 2026 11:25:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109839&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Immunitas社の前臨床段階の炎症疾患治療抗体をBoehringer Ingelheimが手にする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109838&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109838&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 13 May 2026 10:12:42 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109838&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 肝臓からの蛋白質が脳に入らずとも脳のアルツハイマー病特徴を軽減</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109837&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109837&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 13 May 2026 08:57:42 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109837&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] NRG1遺伝子融合陽性（NRG1+）胆管癌へのPartner社のBizengri使用を米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109836&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109836&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 16:15:20 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109836&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Braveheart/Hengruiの肥大型心筋症薬がPh2試験で単なる症状緩和以上の効果示す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109835&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109835&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 15:53:33 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109835&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Novo社の細胞任せのパーキンソン病治療STEM-PDをCellular社が手に入れる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109834&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109834&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 15:03:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109834&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] InhibrxのOX40活性化薬INBRX-106込み頭頸部癌初治療Ph2試験奏効率が有望</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109833&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109833&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 12:52:41 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109833&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] GSKのB型肝炎薬bepirovirsenをSino Biopharmaceuticalが中国で売る</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109832&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109832&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 12:11:10 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109832&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] GLP-1を作る遺伝子治療RJVA-001の臨床試験開始許可をFractyl Healthが手にした</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109831&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109831&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 11:26:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109831&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] GSKのマラリアワクチンMosquirixが小児8人に1人の死を防いだ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109830&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109830&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 11:01:49 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109830&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 独Merckの抗TLR7/8薬enpatoranのSLE相手の目標未達成Ph2試験結果論文報告</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109829&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109829&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 10:18:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109829&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脳卒中患者への血栓溶解薬投与と時を同じくしての抗血小板薬2種併用が有益</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109828&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109828&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 12 May 2026 08:42:02 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109828&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 発症後24時間以内のコア梗塞大きめ虚血性脳卒中患者の血栓剥ぎ取り治療が有益</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109827&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109827&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 11 May 2026 16:59:42 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109827&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 【増補版】サイロシビンで3人に1人近くがコカイン依存を脱却</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109826&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109826&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 11 May 2026 10:14:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109826&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] サイロシビンのコカイン断ち効果が無作為化試験で示された</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109825&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109825&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 10 May 2026 16:40:33 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109825&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] テストステロンの脳腫瘍抑制効果を発見</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109824&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109824&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 10 May 2026 09:49:46 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109824&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 内臓脂肪を溜めずにいると主に血糖制御改善により脳が好調に保たれるらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109823&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109823&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 09 May 2026 16:56:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109823&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] にんにく成分S1PCが脳の視床下部を介した仕組みで老化筋肉の機能を改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109822&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109822&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 09 May 2026 16:42:27 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109822&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] マウスの脂肪肝が喘息薬フォルモテロールで概ね解消</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109821&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109821&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 09 May 2026 15:59:10 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109821&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 英国バース大学が開発するハンタウイルスワクチンのPh1試験が近々始まる見込み</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109820&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109820&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 09 May 2026 13:09:52 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109820&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Biogenのアルツハイマー病薬を最初から皮下注射する用途の米国審査3か月延長</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109819&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109819&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認申請</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 09 May 2026 12:10:43 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109819&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ラパマイシンのポリマーがポナチニブを包んで作るナノ粒子で静脈奇形が退縮</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109818&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109818&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 09 May 2026 11:00:59 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109818&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] NET（好中球細胞外トラップ）除去/阻止で筋骨格損傷後異所性骨化を阻止しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109817&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109817&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 09 May 2026 09:43:28 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109817&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 固形癌にの増殖をより一層抑制する定住ナチュラルキラー細胞（trNK細胞）同定</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109816&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109816&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 09 May 2026 08:56:14 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109816&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] RBPMS阻害で急性骨髄性白血病の進行を食い止めうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109815&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109815&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 08 May 2026 16:59:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109815&amp;ref=rss</comments>
	</item>
</channel>
</rss>
